Nobelpharma America, Llc

Nobelpharma America, Llc company information, Employees & Contact Information

Nobelpharma develops medicines and medical devices with a focus on underserved patient populations and undertreated medical conditions. Visit our website at https://www.nobelpharma-us.com

Company Details

Employees
22
Founded
-
Address
4520 East West Hwy, Bethesda,maryland 20814,united States
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Bethesda, Maryland
Looking for a particular Nobelpharma America, Llc employee's phone or email?

Nobelpharma America, Llc Questions

News

NOBELPHARMA LAUNCHES NEW STORYBOOK TO HELP PARENTS AND CHILDREN WITH RARE DISEASE - PR Newswire

NOBELPHARMA LAUNCHES NEW STORYBOOK TO HELP PARENTS AND CHILDREN WITH RARE DISEASE PR Newswire

Nobelpharma America launches educational website to boost awareness for rare nerve disease - Fierce Pharma

Nobelpharma America launches educational website to boost awareness for rare nerve disease Fierce Pharma

Nobelpharma America Debuts New Product, HYFTOR™ (sirolimus topical gel) 0.2%, at the 2022 World TSC Conference - BioSpace

Nobelpharma America Debuts New Product, HYFTOR™ (sirolimus topical gel) 0.2%, at the 2022 World TSC Conference BioSpace

Small pharma takes a rare approach to treat neglected diseases - Nature

Small pharma takes a rare approach to treat neglected diseases Nature

Sirolimus Topical Gel Available for Facial Angiofibroma Associated With Tuberous Sclerosis Complex - NeurologyLive

Sirolimus Topical Gel Available for Facial Angiofibroma Associated With Tuberous Sclerosis Complex NeurologyLive

Japanese Company Opens American Headquarters In Bethesda - Montgomery Community Media

Japanese Company Opens American Headquarters In Bethesda Montgomery Community Media

Rare Disease, Facial Angiofibroma Associated with Tuberous Sclerosis Complex (TSC), is Focus of New Disease Education Website Launched by Nobelpharma America - PR Newswire

Rare Disease, Facial Angiofibroma Associated with Tuberous Sclerosis Complex (TSC), is Focus of New Disease Education Website Launched by Nobelpharma America PR Newswire

AllianceRx Walgreens Pharmacy, Total Care Rx Chosen to Distribute to Hyftor - Managed Healthcare Executive

AllianceRx Walgreens Pharmacy, Total Care Rx Chosen to Distribute to Hyftor Managed Healthcare Executive

Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations - citybiz

Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations citybiz

$9.7 million approved by Texas Space Commission for SEARF grant awards - Odessa American

$9.7 million approved by Texas Space Commission for SEARF grant awards Odessa American

FDA Approves Sirolimus Topical Gel for Facial Angiofibroma - HCPLive

FDA Approves Sirolimus Topical Gel for Facial Angiofibroma HCPLive

In a first, FDA approves topical sirolimus for rare disease lesions - Fierce Pharma

In a first, FDA approves topical sirolimus for rare disease lesions Fierce Pharma

HYFTOR™ (sirolimus topical gel) 0.2%, the first FDA-approved topical treatment for facial angiofibroma associated with tuberous sclerosis, is now available in the US - BioSpace

HYFTOR™ (sirolimus topical gel) 0.2%, the first FDA-approved topical treatment for facial angiofibroma associated with tuberous sclerosis, is now available in the US BioSpace

FDA Action Update, August 2022: Responses, Extensions, and Approvals - NeurologyLive

FDA Action Update, August 2022: Responses, Extensions, and Approvals NeurologyLive

TSC Alliance® Announces 24th Annual Step Forward to Cure TSC® - The Malaysian Reserve

TSC Alliance® Announces 24th Annual Step Forward to Cure TSC® The Malaysian Reserve

Rare Disease Treatment, HYFTOR® (sirolimus topical gel) 0.2% Coverage Expanded by Medicaid, Including in Key U.S. States - PR Newswire

Rare Disease Treatment, HYFTOR® (sirolimus topical gel) 0.2% Coverage Expanded by Medicaid, Including in Key U.S. States PR Newswire

HYFTOR™ (sirolimus topical gel) 0.2% Available Through AllianceRx Walgreens Pharmacy - PR Newswire

HYFTOR™ (sirolimus topical gel) 0.2% Available Through AllianceRx Walgreens Pharmacy PR Newswire

Top Nobelpharma America, Llc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant